ARCHIVES

Advisors Ok New RFP For Natural Product Large-Scale Production

This article is from The Cancer Letter archive.

Vol. 18 No. 10 | March 6, 1992

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says

April 27, 1979

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Six Scientists Win Lasker Awards; UCLA Opens Liver Cancer Center; Foundation Honors Murphy.

September 22, 2000

Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach

February 7, 2014

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003